Search by Drug Name or NDC

    NDC 10122-0820-28 BETHKIS 300 mg/4mL Details

    BETHKIS 300 mg/4mL

    BETHKIS is a RESPIRATORY (INHALATION) SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Chiesi USA, Inc.. The primary component is TOBRAMYCIN.

    Product Information

    NDC 10122-0820
    Product ID 10122-820_32442297-00c4-4800-b7c4-1e2e290f3162
    Associated GPIs 07000070002530
    GCN Sequence Number 064682
    GCN Sequence Number Description tobramycin AMPUL-NEB 300 MG/4ML INHALATION
    HIC3 W1F
    HIC3 Description AMINOGLYCOSIDE ANTIBIOTICS
    GCN 16122
    HICL Sequence Number 017765
    HICL Sequence Number Description TOBRAMYCIN
    Brand/Generic Brand
    Proprietary Name BETHKIS
    Proprietary Name Suffix n/a
    Non-Proprietary Name tobramycin
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form SOLUTION
    Route RESPIRATORY (INHALATION)
    Active Ingredient Strength 300
    Active Ingredient Units mg/4mL
    Substance Name TOBRAMYCIN
    Labeler Name Chiesi USA, Inc.
    Pharmaceutical Class Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA201820
    Listing Certified Through 2024-12-31

    Package

    NDC 10122-0820-28 (10122082028)

    NDC Package Code 10122-820-28
    Billing NDC 10122082028
    Package 7 POUCH in 1 CARTON (10122-820-28) / 4 AMPULE in 1 POUCH / 4 mL in 1 AMPULE
    Marketing Start Date 2013-04-15
    NDC Exclude Flag N
    Pricing Information N/A